156 related articles for article (PubMed ID: 32724885)
1. Predictor of outcome after living donor liver transplantation for patients with hepatocellular carcinoma beyond the Japan criteria.
Yonemura Y; Yoshizumi T; Inokuchi S; Kosai-Fujimoto Y; Harada N; Itoh S; Toshima T; Takeishi K; Yoshiya S; Mori M
Ann Gastroenterol Surg; 2020 Jul; 4(4):413-421. PubMed ID: 32724885
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of des-γ-carboxyl prothrombin in living-donor liver transplantation for recurrent hepatocellular carcinoma.
Harimoto N; Yoshida Y; Kurihara T; Takeishi K; Itoh S; Harada N; Tsujita E; Yamashita YI; Uchiyama H; Soejima Y; Ikegami T; Yoshizumi T; Kawanaka H; Ikeda T; Shirabe K; Saeki H; Oki E; Kimura Y; Maehara Y
Transplant Proc; 2015 Apr; 47(3):703-4. PubMed ID: 25819732
[TBL] [Abstract][Full Text] [Related]
3. Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital.
Togashi J; Akamastu N; Kokudo N
Hepatobiliary Surg Nutr; 2016 Oct; 5(5):399-407. PubMed ID: 27826554
[TBL] [Abstract][Full Text] [Related]
4. Elevated Alfa-Fetoprotein and Des-Gamma-Carboxy Prothrombin Levels Predict Poor Outcomes After Liver Transplantation for Hepatocellular Carcinoma Beyond the Japan Criteria.
Ishii M; Ibuki S; Morinaga J; Shimata K; Hirukawa K; Isono K; Honda M; Sugawara Y; Inomata Y; Hibi T
Transplant Proc; 2023 Apr; 55(3):606-612. PubMed ID: 37005157
[TBL] [Abstract][Full Text] [Related]
5. Treatment strategy for hepatocellular carcinoma recurrence in the transplant era: Focusing on the Japan criteria.
Yoshiya S; Harada N; Toshima T; Toshida K; Kosai Y; Tomino T; Nagao Y; Kayashima H; Itoh S; Yoshizumi T
Surg Today; 2024 Jan; 54(1):64-72. PubMed ID: 37289265
[TBL] [Abstract][Full Text] [Related]
6. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation.
Taketomi A; Sanefuji K; Soejima Y; Yoshizumi T; Uhciyama H; Ikegami T; Harada N; Yamashita Y; Sugimachi K; Kayashima H; Iguchi T; Maehara Y
Transplantation; 2009 Feb; 87(4):531-7. PubMed ID: 19307789
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
[TBL] [Abstract][Full Text] [Related]
8. Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value.
Shimada M; Yonemura Y; Ijichi H; Harada N; Shiotani S; Ninomiya M; Terashi T; Yoshizumi T; Soejima Y; Maehara Y
Transplant Proc; 2005 Mar; 37(2):1177-9. PubMed ID: 15848661
[TBL] [Abstract][Full Text] [Related]
9. Surgical management of hepatocellular carcinoma in Child-Pugh class B cirrhotic patients: hepatic resection and/or microwave coagulation therapy versus living donor liver transplantation.
Harada N; Shirabe K; Ikeda Y; Korenaga D; Takenaka K; Maehara Y
Ann Transplant; 2012 Dec; 17(4):11-20. PubMed ID: 23274319
[TBL] [Abstract][Full Text] [Related]
10. Two-step selection criteria for living donor liver transplantation in patients with hepatocellular carcinoma.
Yoshizumi T; Ikegami T; Toshima T; Harimoto N; Uchiyama H; Soejima Y; Yamashita Y; Shirabe K; Maehara Y
Transplant Proc; 2013 Nov; 45(9):3310-3. PubMed ID: 24182807
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
Ninomiya M; Shirabe K; Facciuto ME; Schwartz ME; Florman SS; Yoshizumi T; Harimoto N; Ikegami T; Uchiyama H; Maehara Y
J Am Coll Surg; 2015 Mar; 220(3):297-304.e3. PubMed ID: 25617912
[TBL] [Abstract][Full Text] [Related]
12. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma.
Soejima Y; Taketomi A; Yoshizumi T; Uchiyama H; Aishima S; Terashi T; Shimada M; Maehara Y
Transplantation; 2007 Apr; 83(7):893-9. PubMed ID: 17460559
[TBL] [Abstract][Full Text] [Related]
13. Living donor liver transplantation for hepatocellular carcinoma: results of prospective patient selection by Kyushu University Criteria in 7 years.
Uchiyama H; Itoh S; Yoshizumi T; Ikegami T; Harimoto N; Soejima Y; Harada N; Morita K; Toshima T; Motomura T; Maehara Y
HPB (Oxford); 2017 Dec; 19(12):1082-1090. PubMed ID: 28888776
[TBL] [Abstract][Full Text] [Related]
14. Impact of tumor size, number of tumors and neutrophil-to-lymphocyte ratio in liver transplantation for recurrent hepatocellular carcinoma.
Yoshizumi T; Ikegami T; Yoshiya S; Motomura T; Mano Y; Muto J; Ikeda T; Soejima Y; Shirabe K; Maehara Y
Hepatol Res; 2013 Jul; 43(7):709-16. PubMed ID: 23190306
[TBL] [Abstract][Full Text] [Related]
15. Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma.
Shindoh J; Sugawara Y; Nagata R; Kaneko J; Tamura S; Aoki T; Sakamoto Y; Hasegawa K; Tanaka T; Kokudo N
Transpl Int; 2014 Apr; 27(4):391-8. PubMed ID: 24472068
[TBL] [Abstract][Full Text] [Related]
16. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
Lee KW; Yi NJ; Suh KS
Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
[TBL] [Abstract][Full Text] [Related]
17. Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma.
Fujiki M; Takada Y; Ogura Y; Oike F; Kaido T; Teramukai S; Uemoto S
Am J Transplant; 2009 Oct; 9(10):2362-71. PubMed ID: 19656125
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.
Hwang S; Lee SG; Joh JW; Suh KS; Kim DG
Liver Transpl; 2005 Oct; 11(10):1265-72. PubMed ID: 16184545
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
[TBL] [Abstract][Full Text] [Related]
20. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
Lee EC; Kim SH; Shim JR; Park SJ
Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
